Nuwellis decoration

Newsroom

Newsroom

Press Releases

Date Title and Summary Additional Formats
August 31, 2022
Nuwellis Announces New Clinical Data Demonstrating 100% Survival at 30 Days Following Use of Ultrafiltration in High-Risk Postoperative Coronary Artery Bypass Grafting (CABG) Patients
Data show ultrafiltration for post-operative CABG patients provides a safe and effective method for managing fluid balance and reducing mortality rates MINNEAPOLIS , Aug. 31, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of
August 25, 2022
U.S. Patent and Trademark Office Awards Nuwellis Patent for Innovative Pediatric Technology
Enabling improved fluid balance and safety when performing dialysis and hemofiltration in pediatrics and neonates MINNEAPOLIS , Aug. 25, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) a commercial stage company dedicated to transforming the lives of patients suffering from fluid overload,
August 19, 2022
Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
MINNEAPOLIS , Aug. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective August 18, 2022 , the independent directors approved equity awards under Nuwellis’ 2021 Inducement Plan, as material inducements to six individuals entering into employment with the
August 19, 2022
Nuwellis Inc. to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
MINNEAPOLIS , Aug. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually. Members of management are scheduled to present on Wednesday, August 31, 2022 at
August 9, 2022
Nuwellis, Inc. Announces Second Quarter 2022 Financial Results
MINNEAPOLIS , Aug. 09, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the second quarter ended June 30, 2022 , which included the following highlights: Generated $2.2 million in total revenue for the second quarter 2022, up 15% sequentially from the first
July 26, 2022
Nuwellis Announces the Submission of the AVOID-HF Clinical Analysis as a Late Breaking Clinical Trial at HFSA
The Finkelstein-Schoenfeld Method of Win Ratios Analysis Provides New Insights Into Superiority of Ultrafiltration over Diuretics in Treating Fluid Overloaded Heart Failure Patients Resistant to Diuretics MINNEAPOLIS , July 26, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc.
July 14, 2022
Nuwellis, Inc. To Announce Second Quarter 2022 Financial Results on August 9, 2022
MINNEAPOLIS , July 14, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its second quarter 2022 financial results will be released on Tuesday, August 9, 2022 . The company will host a conference call and webcast at 9:00 AM ET , during which management will discuss the
July 12, 2022
Nuwellis Initiates Its Outpatient Heart Failure Strategy Using Aquadex Ultrafiltration Therapy
MINNEAPOLIS , July 12, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on improving the quality of life for people with fluid overload, today announced key takeaways from its recent physician-led webinar discussing the benefits of treating fluid overloaded
June 29, 2022
Nuwellis Announces First Patient Enrolled in its Pivotal Trial REVERSE-HF
REVERSE-HF will evaluate ultrafiltration therapy in comparison to IV diuretics to treat heart failure patients with fluid overload MINNEAPOLIS , June 29, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced the first patient has been enrolled in the company’s pivotal REVERSE-HF
June 14, 2022
Nuwellis Expands Pediatric Access to Ultrafiltration Therapy at Hospitals in Florida and Arkansas
Pediatric Segment Growth Continues at 36% CAGR MINNEAPOLIS , June 14, 2022 (GLOBE NEWSWIRE) -- Improving access to life-saving fluid management therapies is a commitment by which Nuwellis, Inc. (Nasdaq: NUWE) stands. The company today announced its Aquadex SmartFlow® system is now available at two
Displaying 11 - 20 of 30

Upcoming Events

More events are coming soon.
jump